These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1069556)

  • 1. Immunotherapy of chronic myelocytic leukemia: effects of different vaccination schedules.
    Sokal JE; Aungst CW; Snyderman M; Gomez G
    Ann N Y Acad Sci; 1976; 277(00):367-83. PubMed ID: 1069556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials in vaccination with leukemia associated antigens in acute myelogenous leukemia.
    Alsabti EA; Taleb AM; Raji HM; Kalil OZ; Saleh KA
    Jpn J Exp Med; 1979 Jun; 49(3):157-68. PubMed ID: 385948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress report on immunotherapy of chronic myeloid leukemia.
    Sokal JE; Carpenter N; Nizet C
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):294-305. PubMed ID: 282900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses to leukemia-associated antigens during immunotherapy of chronic myelocytic leukemia.
    Ramachandar K; Baker MA; Taub RN
    Blood; 1975 Dec; 46(6):845-54. PubMed ID: 1060471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG immunotherapy in chronic myelocytic leukemia.
    Kardaszewicz E; Siejeńska L
    Pol Med Sci Hist Bull (1973); 1976; 15(2):225-9. PubMed ID: 1066660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCG immunotherapy in chronic myelocytic leukaemia.
    Kardaszewicz E; Siejeńska L
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):32-5. PubMed ID: 1063221
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy of chronic myelocytic leukemia.
    Sokal JE; Aungst CW; Grace JT
    Natl Cancer Inst Monogr; 1973 Dec; 39():195-8. PubMed ID: 4595316
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy with BCG and leukemic blast cells during complete remission of acute myeloid leukemia.
    Gobbi M; Ruggero D; Baccarani M; Zaccaria A; Tomasini I; Tura S
    Haematologica; 1977 Oct; 62(5):529-36. PubMed ID: 412739
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemoimmunotherapy for maintenance in acute myeloblastic leukemia.
    Whiteside MG; Cauchi MN; Paton C; Stone J
    Cancer; 1976 Oct; 38(4):1581-6. PubMed ID: 1068741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of immunotherapy in acute myelogenous leukemia.
    Foon KA; Smalley RV; Riggs CW; Gale RP
    Arch Intern Med; 1983 Sep; 143(9):1726-31. PubMed ID: 6577818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse.
    Powles R; Toy JL
    Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of leukemia and lymphoma.
    Murphy S; Hersh E
    Semin Hematol; 1978 Apr; 15(2):181-203. PubMed ID: 418506
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of administration of BCG, levamisole and irradiated leukemic cells on immune status and remission status in chronic myelogenous leukemia.
    Advani SH; Gulwani B; Ghogale SG; Shetye MR; Gangal SG
    Oncology; 1985; 42(5):275-81. PubMed ID: 3897932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy in the management of myelogenous leukemia.
    Fairley GH
    Arch Intern Med; 1976 Dec; 136(12):1406-12. PubMed ID: 793553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants.
    Mastrangelo MJ; Berd D; Bellet RE
    Ann N Y Acad Sci; 1976; 277(00):94-123. PubMed ID: 793490
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunotherapy for acute myelogenous leukemia.
    Powles RL; Lister TA; Crowther D; McElwain T; Alexander P; Fairley GH
    Bibl Haematol; 1975; (40):737-49. PubMed ID: 1057948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of cancer patients with Bacillus Calmette-Guérin: summary of four years of experience in Japan.
    Torisu M; Fukawa M; Nishimura M; Harasaki H; Kai S; Tanaka J
    Ann N Y Acad Sci; 1976; 277(00):160-86. PubMed ID: 1069547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic myeloid leukemia--attempts at finding new methods of treatment].
    Gahrton G
    Lakartidningen; 1975 Nov; 72(46):4492-6. PubMed ID: 1059867
    [No Abstract]   [Full Text] [Related]  

  • 19. [BCG immunotherapy in chronic myeloid leukemia].
    Kardaszewicz E; Siejeńska L
    Pol Arch Med Wewn; 1975 Jul; 54(1):7-13. PubMed ID: 1057161
    [No Abstract]   [Full Text] [Related]  

  • 20. Modifying the biological response to acute myeloid leukemia I. BCG, allogeneic leukemic cells and spontaneous cytotoxicity.
    Arends-Merino A; Sjögren AM; Reizenstein P
    Anticancer Res; 1983; 3(4):239-41. PubMed ID: 6576728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.